Samura B. Influence of atorvastatin therapy on biological markers and cardiovascular risk in patients with chronic lymphocytic leukemia in remission. Zaporozhye Medical Journal [Internet]. 2019Feb.8 [cited 2024Dec.23];(1). Available from: http://zmj.zsmu.edu.ua/article/view/155793